Quantcast
Tuesday, April 23, 2024

Trans Activists Push Bogus Research on Benefits of Childhood Transitions

'If Pfizer is producing hormone therapies, then of course there’s incentives to promote studies that push those... '

(Jacob Bruns, Headline USA) A transgender activist published a study suggesting a plethora of benefits that emerge from childhood genital mutilation, the Daily Caller reported.

Pharmaceutical companies have also bolstered the so-called studies with additional data and research promoting their products. In partnership with psychiatrists, they suggested that hormone therapy, puberty blockers, and other manipulative medical techniques support the ‘mental health’ of children.

The term ‘mental health’ has become a sweeping term used to justify state intervention at every twist and turn.

“Research suggests that accepting a child’s affirmed gender identity and expression can decrease the risk of future psychiatric problems,” the American Academy of Child and Adolescent Psychiatry repeated.

Dr. Diana Blum, a California neurologist, pointed out that Albert Bourla’s Pfizer has gotten into the transgender game.

“If Pfizer is producing hormone therapies, then of course there’s incentives to promote studies that push those,” she said.

She also noted that so-called academic journals are funded by those same industries.

“Even though things get published in academic journals, a lot of the funding comes from the pharmaceutical industry,” Blum said.

She also noted that scientists operating the study ultimately used illegitimate methods.

“This was not a double-blind placebo-controlled trial where you can actually say they tested a hypothesis and here’s the conclusion and here’s why you know it’s valid,” she explained.

An additional study conducted by Stanford University simply surveyed people and presented its findings as unquestionably true.

“The Stanford study used surveys,” Blum said.

“Right off the bat there are confounding variables never taken into account and thus inappropriate conclusions and generalizations are made that may not apply to the patient population studied,” she said.

Copyright 2024. No part of this site may be reproduced in whole or in part in any manner other than RSS without the permission of the copyright owner. Distribution via RSS is subject to our RSS Terms of Service and is strictly enforced. To inquire about licensing our content, use the contact form at https://headlineusa.com/advertising.
- Advertisement -

TRENDING NOW

TRENDING NOW